26th Annual Meeting of the American Venous Forum (AVF)
Upcoming SlideShare
Loading in...5
×
 

26th Annual Meeting of the American Venous Forum (AVF)

on

  • 965 views

 

Statistics

Views

Total Views
965
Views on SlideShare
964
Embed Views
1

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 1

http://www.mdconferencefinder.com 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

26th Annual Meeting of the American Venous Forum (AVF) 26th Annual Meeting of the American Venous Forum (AVF) Document Transcript

  • Preliminary Program NewOrleans The American Venous Forum TH 26 ANNUAL MEETING FEBRUARY 19-22, 2014 The Roosevelt New Orleans, LA
  • Table of Contents Message from the President . . . . . . . . . . . . . . . 1 AVF Programs & Initiatives . . . . . . . . . . . . . . . . 2 AVF 26th Annual Meeting . . . . . . . . . . . . . . . . . . 3 AVF & Foundation Leadership . . . . . . . . . . . . . 3 Schedule At A Glance . . . . . . . . . . . . . . . . . . . . 4 David S. Sumner Venous Summit. . . . . . . . . . . 5 Specialty Symposia. . . . . . . . . . . . . . . . . . . . . . 6 Meeting Program. . . . . . . . . . . . . . . . . . . . . . . . 9 Poster Presentations. . . . . . . . . . . . . . . . . . . . 16 Hotel & Travel Information. . . . . . . . . . . . . . . . 18 Registration Information . . . . . . . . . . . . . . . . . 19 Registration Form . . . . . . . . . . . . . . . . . . . . . . 20 About AVF Program Committee The American Venous Forum (AVF) is dedicated to improving the care of patients with venous and lymphatic disease. Founded in 1987, AVF fosters cutting edge research and clinical innovation and educates health care professionals, patients and policy makers about venous and lymphatic diseases. AVF’s leadership and membership are recognized internationally as thought leaders, expert investigators and clinicians in venous and lymphatic health care. Suresh Vedantham, MD Dates to Remember Accreditation
  • Message from the President I invite you to attend the American Venous Forum’s 26th Annual Meeting in New Orleans, research. I hope the Annual Meeting provides an opportunity for each participant to gain new insights into how venous and lymphatic health is evolving and to take advantage of rapidly developing technologies. I am also excited that there will be some new offerings at the Annual Meeting. management and mismanagement of venous and lymphatic disease. The Venous Summit panel will consist of experts in venous disease, research, insurance, and law. discussion about their research. As an added bonus this year, the Meeting will feature more than eighty poster presentations and displays. The top presenters will be announced during the Mardi Gras Soirée. February 20. The Symposium will focus on the approach to acute venous thromboembolism, with emphasis on acute of low molecular weight heparins, and more recently, the availability of new oral anticoagulants. The symposium will offer state of the art therapy review. of February 20. Dr. Smith is an international expert in the venous thrombosis pathophysiology. The emphasis of his research is on the elucidating mechanisms that regulate thrombus resolution and the development and maintenance of venous valves. New this year, the Annual Meeting will offer participants the option to attend two of the six Specialty Symposia In the spirit of New Orleans, we will have a Mardi Gras Soirée to close out the meeting on the evening of February 21. The Soirée will provide the opportunity for participants to engage with old and new colleagues in a relaxed setting and congratulate award recipients all while immersing in New Orleans culture with live music and cuisine. Peter K. Henke, MD President American Venous Forum 1
  • AVF Programs and Initiatives its goals and advance the mission. of the AVF bring together internationally recognized authorities on all aspects of venous disease, diagnosis, pathophysiology and treatment. The objectives of these comprehensive meetings are to provide attendees with knowledge of current thinking in effective clinical management of venous disease and components that addresses the need for more venous education during vascular training. is designed to broaden understanding and awareness about venous disease and ultimately reduce the morbidity and mortality associated with venous disorders. Screening Kits, for conducting free public venous screenings, are available at a reduced cost to AVF Members. reviews, venous and lymphatic images and practice management manuscripts related to all aspects of venous disease, lymphatic disease and wound care. ® (VQI) is designed to improve vascular health care. It provides an opportunity for effort to improve patient care. physicians treating venous disease. Members of the AVF contribute their time and expertise people with venous disease. Membership is open to all healthcare professionals who treat venous disease, 2
  • AVF 26th Annual Meeting On behalf of The American Venous Forum, we invite you to join us at the 26th Annual Meeting on February been a long standing leader in education and research promoting venous and lymphatic health. AVF Annual Meetings bring together internationally recognized thought leaders, expert investigators and clinicians in venous and lymphatic disease. The AVF is comprised of over 750 members who are primarily physicians and surgeons in the treatment of venous and lymphatic disease. The AVF Annual Meeting has been growing each year and this year we expect over 600 attendees and associates from the United States and around the world. This year we gather in New A select group of companies have been invited to participate in the 26th Annual Meeting, either as sponsors or exhibitors. The exhibits will feature the latest products for diagnosis and treatment of venous interventional radiologists, interventional cardiologists, phlebologists, plastic surgeons, physician assistants, vascular nurse practitioners, technicians, technologists and other medical professionals who are currently treating venous disease. participants an opportunity to visit the various companies in attendance. cocktail reception, New Orleans cuisine and a live New Orleans jazz band. An awards presentation will include best paper and best poster awards, Servier Traveling Fellowship announcement and recognition of the 2014 AVF & Foundation Leadership Lowell S. Kabnick, MD Brennan Marilla Antonios P. Gasparis, MD Brajesh K. Lal, MD Robert B. McLafferty, MD Thomas F. O’Donnell, MD Sandra Shaw Suresh Vedantham, MD 3
  • Schedule At A Glance (New Members Only) (Non Members Only) 4
  • David S. Sumner Venous Summit Chair: Fedor Lurie, MD An expected side effect of increasing number of practitioners who treat patients with venous disease is a substantial general. Time has come for professional societies to take a hard look at this situation and decide what can be done of care for venous disease, existing evidence supporting management strategies when complications occur, and about ethical, legal and reimbursement issues involved in management of such cases. The discussion is expected on the effective ways to deal with reimbursement challenges. course is by separate subscription. Lowell S. Kabnick, MD Alun Davies, MD Thom Rooke, MD Mark Meissner, MD Peter Lawrence, MD George McPheeters, MD Nick Morrison, MD D. Eugene Strandness Memorial Lecture Keynote Speaker: Alberto Smith, PhD Alberto Smith is a Professor of Vascular Science and Head of the Academic Department of Surgery at King’s venous disease. The emphasis of his research is on the elucidating mechanisms that regulate thrombus resolution and the development and maintenance of venous valves. This work is carried out using both models of disease
  • Specialty Symposia The 26th Chair: Suresh Vedantham, MD Chair: Steven Elias, MD Akhilesh Sista, MD Suman Rathbun, MD Nick Morrison, MD Suresh Vedantham, MD Chair: Thom Rooke, MD Chair: Thom Rooke, MD Steven Dean, MD Steven Dean, MD Thom Rooke, MD Thom Rooke, MD Chair: Colleen Moore, MD Chair: Colleen Moore, MD Kathleen Ozsvath, MD Kathleen Ozsvath, MD Audra Duncan, MD Audra Duncan, MD Chair: José Antonio Diaz, MD Chairs: Ghassan Kassab, MD & Fedor Lurie, MD Seshadri Raju, MD Alberto Smith, MD Fedor Lurie, MD Daniel Myers, DVM Michael Sacks, MD Antonio Rosales, MD Zachary Berwick, MD
  • Specialty Symposia The session on lymphedema and compression is The Deep Venous Disease Symposium at the AVF Annual Meeting will address some of the most advances in compression therapy and lymphedema. Dr. Manju Kalra will discuss strategies for improved patient compliance and improved patient selection for different methods of compression. New advances in lymphedema management, including surgical interventions will be addressed by Dr. Audra Duncan. Dilemas of treating patients with concomitant venous and lymphatic disease extensive acute DVT? How can physiological testing augment a physician’s approach to the management interventions actually work for patients with chronic iliofemoral thrombosis? And how are physicians and the AVF working together to lay the groundwork for ensuring to provide practical solutions to problems encountered has a wonderful and growing tradition of multidiscplinary collaboration in education. This session will feature an outstanding and diverse array of talented DVT experts from interventional radiology, vascular surgery, and Moore. Animal models of venous thrombosis (VT) have been used for many years and have highly contributed to the current understanding of VT biology. Over the past two decades, several models of VT have been says session chair Dr. Suresh Vedantham, Professor School of Medicine. thrombogenesis associated with any animal model correlates with spontaneous VT formation in humans, have the pleasure of moderating a session devoted accurate or representative of the disease. Oftentimes, investigators from different backgrounds are subject to contradictory debates regarding the same VT animal will include Steve Dean from The Ohio State University Dr. Dean is widely recognized by the Vascular Medicine subjective judgment of manuscripts and grant reviews, which impedes the efforts of investigators throughout their process of understanding VT. Leaders in animal models of VT have been invited to the Annual Meeting in order to initiate a public discussion in the format of a Specialty Symposium regarding the advantages and disadvantages of such models. vascular disorders. He is an extremely popular speaker or downright bizarre. Dr. Dean is about to publish a medical atlas of vascular diseases that will showcase vascular medicine practitioner with a reputation for teaching excellence and a strong interest in thrombotic an issue that is gaining wide attention as new, novel oral anticoagulants enter the market. It is precisely the type of talk one expects from a nonsurgical practitioner impressive expertise in this area. Time permitting, the moderator will present a short discussion of heparin to pose a problem for every practitioner who deals with to be an informative, interesting, and useful session. 7
  • Specialty Symposia This session will be both didactic and interactive. AVF was initiated in 2012 by past AVF President Dr. Seshadri Raju to bring basic science and analytical engineering approaches to bear on clinical venous as well. The attendees will then discuss their experience are welcome and expected. Schonbein chaired the well attended inaugural session. The objective was to stimulate understanding and collaborations between basic scientists, engineers and clinicians to address important issues in venous health care. In the spirit of this initiative, the 2014 session will be devoted to venous valves where basic science, engineering, and clinical knowledge will be interfaced to highlight native valve function, role of valves in venous disease and treatment methods (surgical, prosthesis, stenting, etc.). Attendees will understand the need and challenges of incorporating the management of cosmetic vein disease into an academic practice. The symposium will educate attendees on the various treatment options for the technical obstacles of endovenous ablation and how to Villavicencio Symposium Chair: Victor Tapson, MD Alex Spyropoulos, MD The 2014 Villavicencio Symposium will focus on the approach to acute venous thromboembolism, with Victor Tapson, MD decades with the increased use of low molecular weight heparins, and more recently, the availability of new oral 1. Attendees will gain an appreciation for the general approach to the treatment of acute venous thromboembolism, and be able to state when and how new oral anticoagulants are effectively utilized, and when warfarin is appropriate. these new oral agents in acute deep venous thrombosis regard to their use, however, are important for clinicians with increasing placement with the expectation of 3. Attendees will be able to list and discuss several has been more controversial. Systemic thrombolytic thrombolytic therapy, systemic thrombolytics, and acute pulmonary embolectomy. 4. Attendees will be able to describe the types of patients that might be appropriate for a more aggressive approach to acute pulmonary embolism. embolectomy and other novel therapeutic maneuvers have evolved and are being increasingly utilized for patients with more extensive emboli. Our symposium will offer the attendee a general understanding of the approach to these different clinical scenarios. 8
  • Meeting Program J. El-Sheikha, S. Nandhra, T. Wallace, N. Samuel, D. Carradice, I. Chetter; Academic Vascular Unit Hull, Hull, United Kingdom Chair: Fedor Lurie, MD Lowell Kabnick, MD E. F. Evans1, C. Daugherty2; 1BTG International Ltd, West Conshohocken, PA, 2BTG International Ltd, West Conshohocken, PA Jose Almeida, MD Alun Davies, MD P. Pittaluga, S. Chastanet; Riviera Veine Institut, Monte Carlo, Monaco Thom Rooke, MD Mark Meissner, MD J. E. Genut, W. A. Marston, A. E. Kouri; University of North Carolina, Chapel Hill, Chapel Hill, NC Peter Lawrence, MD Anthony Comerota, MD James Brazeau, Esq. George McPheeters, MD T. M. Proebstle1, J. Alm2, S. Dimitri3, L. Rasmussen4, M. Whiteley5, J. Lawson6, A. Davies7; 1University of Mainz, Mainz, Germany, 2Dermatoligikum, Hamburg, Germany, 3 The Countess of Chester Hospital, United Kingdom, United Kingdom, 4Danish Vein Centers, Naestved, Denmark, 5The Whiteley Clinic, Guildford, United Kingdom, 6Skin and Vein Clinic Oosterwal, Alkmaar, Netherlands, 7Imperial College, London, United Kingdom Nick Morrison, MD R. F. Merchant, J. W. Daake, K. S. Richards, J. S. Frisbie; The Reno Vein Clinic, Reno, NV U. Jaffer, K. Lackenby, M. A. Anwar, M. Aslam, N. Moderators: Lowell Kabnick, MD, Alun Davies, MD K. Gibson1, M. Meissner2; 1Lake Washington Vascular Surgeons, Bellevue, WA, 2University of Washington Department of Surgery, Seattle, WA Hammersmith Hospital, Du Cane Road, London, United Kingdom J. H. Isobe1, K. C. Sentell1, L. A. Nichols1, C. S. Simms2; 1 Baptist Vein Center, Hoover, AL, 2Princeton Baptist Medical Center, Hoover, AL
  • Meeting Program 2 M. A. F. de Wolf1, R. de Graaf1, R. Kurstjens1, S. Penninx1, C. W. K. P. Arnoldussen2, H. Jalaie3, C. H. A. Wittens1,3; 1Maastricht University Medical Center, Maastricht, Netherlands, 2VieCuri Medical Center, Venlo, Netherlands, 3Universitats Klinikum Aachen, Aachen, Germany 2 S. B. Patel, A. E. Ostler, T. M. Pirie, M. S. Whiteley; The Whiteley Clinic, Guildford, United Kingdom Moderators: David Gillespie, MD, M. Ashraf Mansour, MD Y. Erben, P. Gloviczki, M. Kalra, H. Bjarnason, N. Reed, A. Duncan, G. S. Oderich, M. Fleming, R. De Martino, T. C. Bower; Mayo Clinic, Rochester, MN B. Kheyson, A. Hingorani, E. Ascher, A. Ganelin, N. Marks, E. Iadgarova; Total Vascular Center, Brooklyn, NY W. Marston1, A. Chinubhai2, S. Kao2, L. English2; University of North Carolina, Chapel Hill, NC, 2Veniti Medical, Fremont, CA 1 W. Tien1, H. Y. Chen2, Z. C. Berwick2, J. Krieger3, S. Chambers3, D. Dabiri1, G. Kassab2; 1Department of Aeronautics and Astronautics, University of Washington, Seattle, WA, 2Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, 3COOK Medical®, Bloomington, IN C. W. K. P. Arnoldussen, R. Kurstjens, M. A. F. de Wolf, R. de Graaf, M. Das, C. H. A. Wittens; Maastricht University Medical Centre, Maastricht, Netherlands J. R. DiRito, S. Tharakan; Academy for Medical Science Technology, Hackensack, NJ S. Raju, M. Davis; The Rane Center at St. Dominic, Jackson, MS M. T. O’Brien1, X. A. Caliste1, A. L. Clark1, J. P. Cullen1, D. L. Gillespie2; 1University of Rochester, Rochester, NY, 2 Southcoast Health Systems, New Bedford, MA 10
  • Meeting Program (New J. Kalish, M. Sloan, S. Sarosiek, H. Marks, C. Moreira, N. Hamburg, R. Vilvendhan, A. Farber; Boston Medical Center, Boston, MA Members Only) (Non Members Only) Moderators: Suresh Vedantham, MD, John Blebea, MD C. J. Grilli, M. McGarry, C. Wrigley, G. Kimbiris, D. Leung, M. Garcia; Christiana Care, Newark, DE A. Amin1; L. Blitz2, M. Garcia3, R. Lookstein4, E Simoni5, P. Soukas6; 1Reading Hospital Health System, Reading, PA, 2Chilton Memorial, Pompton Plains, NJ, 3Christiana Care, Newark, DE, 4Mount Sinai Medical Center, NYC, NY, 5Penn State Hershey Heart and Vascular Institute, Hershey, PA, 6Miriam Hospital, Providence, RI M. Mehta, R. Acino, A. J. Comerota, F. Lurie; The Toledo Hospital-Jobst Vascular Institute, Toledo, OH S. P. Grover, A. Patel, P. Saha, O. T. A. Lyons, B. Modarai, J. Humphries, A. Smith; King’s College London, London, United Kingdom Chair: Mark Forrestal, MD E. D. Avgerinos, E. Hager, A. Naddaf, E. Dillavou, M. Singh, R. A. Chaer; University of Pittsburgh, Pittsburgh, PA Diana Neuhardt, RVT Carl Black, MD R. D. Malgor1, M. Comito1, A. P. Gasparis1, P. Pappas2, A. K. Tassiopoulos1, N. Labropoulos1; 1Stony Brook University Medical Center, Stony Brook, NY, 2Brooklyn Hospital, New York City, NY Marlin Schul, MD Nick Morrison, MD A. C. Ring, M. Beck, A. B. Reed, F. Aziz; Penn State University, Hershey, PA Mark Forrestal, MD Lisa Pavone, MD J. J. Lee, M. Al-Jubouri, R. Acino, A. J. Comerota, F. Lurie; The Toledo Hospital-Jobst Vascular Institute, Toledo, OH 11
  • Meeting Program Moderators: Andrew Nicolaides, MD, Nick Morrison, MD Chair: Victor Tapson, MD Alex Spyropoulos, MD Tod Englehardt, MD K.A.L. Darvall, G.R. Bate, A.W. Bradbury; University Department of Vascular Surgery, Birmingham, UK Victor Tapson, MD Moderators: Rabih Chaer, MD, Apostolos Tassiopoulos, MD C. Karathanos1, M. Exarchou1, A. Tsezou2, D. Kyriakou3, C. Wittens4,5, A. Giannoukas1; 1Department of Vascular Surgery, Faculty of Medicine, School of Health Sciences, University of Thessalia, Larissa, Greece, 2Department of Molecular Biology, Faculty of Medicine, School of Health Sciences, University of Thessalia, Larissa, Greece, 3 Department of Haematology, Faculty of Medicine, School of Health Sciences, University of Thessalia, Larissa, Greece, 4Department of Vascular Surgery and Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, Limburg, The Netherlands, 5Department of Vascular Surgery, University Hospital RWTH Aachen, Nordrhein-Westfalen, Germany P. E. Thorpe; Arizona Heart, Phoenix, AZ C. Oostra1, P. Henke2, C. Luke2, R. Acino1, F. Lurie1, A. J. Comerota1; 1The Toledo Hospital-Jobst Vascular Institute, Toledo, OH, 2University of Michigan, Ann Arbor, MI S. Raju, M. Ward, Jr.; The Rane Center at St. Dominic, Jackson, MS C. Fife1, M. Aldrich2, R. Guilliod1, J. Rasmussen1, E. Sevick3, I. Tan4; 1UTHSC Houston, Houston, TX, 2The University of Texas Health Science Center, Houston, TX, 3 University of Texas Health Science Center, Houston, TX, 4UTHSC Houston, Houston, United States T. Yamaki, H. Konoeda, A. Osada, H. Sakurai; Tokyo Women’s Medical University, Tokyo, Japan O. T. A. Lyons, S. Grover, A. Sabine, G. Vizcay-Barrena, E. Bazigou, T. Kum, N. A. Brown, T. Petrova, T. Makinen, A. S. Smith; King’s College London, London, United Kingdom C. R. Lattimer, G. Geroulakos, E. Kalodiki; Ealing Hospital & Imperial College, Middlesex, United Kingdom J. Uhl, C. Gillot; University Paris Descartes, Paris, France Keynote Speaker: Alberto Smith, PhD 12
  • Meeting Program Moderators: Joseph Raffetto, MD, Marc Passman, MD See page 16 Chair: Nick Morrison, MD & Angelo Scuderi, MD Nick Morrison, MD Armando Schapira, MD & Eduardo Tkach, MD The top 20 posters will be presented in the Roosevelt Attilio Cavezzi, MD & Pier Luigi Antignani, MD Marianne De Meiseneer, MD & Mark Meissner, MD Malay Patel, MD & Philip Coleridge-Smith, DM FRCS Kurosh Parsi, MD Angelo Scuderi, MD Moderators: Harold Welch, MD, Paul Pittaluga, MD J. Ulloa, Jr 1, H. Hiller2; 1Fundacion Santa Fe de Bogota, Bogota, Colombia, 2Clinica del Rosario, Medellin, Colombia K. L. Todd, III1, D. Wright2, E. Orfe3; 1Southeast Vein and Laser Center, Dothan, AL, 2BTG International, Ltd., London, United Kingdom, 3BTG International Ltd., West Conshohoken, PA J. Almeida MD1, I. Franklin2; 1Miami Vein Center, Miami, FL, 2The Cadogan Clinic, London, United Kingdom 13
  • Meeting Program Moderators: William Marston, MD, Colleen Moore, MD S. Nandhra, J. El-Sheikha, N. Samuel, T. Wallace, D. Carradice, I. Chetter; Hull-York Medical School, Hull, United Kingdom M. A. Anwar, P. Vorkas, J. Li, J. Shalhoub, C. S. Lim, E. Want, E. Holmes, A. H. Davies; Imperial College London, London, United Kingdom K. D. Menezes, D. G. Nair; Sarasota Memorial Hospital, Sarasota, FL E. V. Shaidakov1, A. G. Grigoryan1, E. A. Ilyukhin2, D. A. Rosukhovskiy1, V. L. Bulatov3; 1Institute of Experimental Medicine of the Russian Academy of Medical Sciences, Saint-Petrsburg, Russian Federation, 2Private surgical clinic “Medalp”, Saint-Petrsburg, Russian Federation, 3 Institute of Bioregulation and Gerontology of the Russian Academy of Medical Sciences, Saint-Petrsburg, Russian Federation R. Velineni, K. Spagou, M. S. Gohel, E. Holmes, A. H. Davies; Imperial College London, London, United Kingdom Carson Oostra, MD Andrea Obi, MD J. A. Diaz1, S. K. Wrobleski1, A. R. Pechota1, A. E. Hawley1, K. J. Roelofs1, N. K. Doornbos1, J. E. Gabriel1, G. Reynolds1, P. Lester1, F. Londy1, S. Lowe1, 1 , D. D. P. K. Henke1, R. G. Schaub2 Myers1; 1University of Michigan, Ann Arbor, MI, 24NKT Therapeutics, Inc., Waltham, MA Xzabia Caliste, MD Brajesh K. Lal, MD Peter J. Pappas, MD C. R. Lattimer1, E. Kalodiki1, M. Azzam1, G. Geroulakos1, J. Fareed2, D. Hoppensteadt2; 1Ealing Hospital & Imperial College, Middlesex, United Kingdom, 2Loyola University Medical Centre, Maywood, IL Jose Almeida, MD Fedor Lurie, MD - President-Elect M. Arata1, Z. Sternberg2; 1Synergy Health Concepts, Newport Beach, CA, 2Department of Neurology, Buffalo Medical Center, Buffalo, NY Peter K. Henke, MD - President H. Chen2, W. Tien1, Z. Berwick2, J. Krieger3, S. Chambers3, D. Dabiri1, G. Kassab4; 1University of Washington, Seattle, WA, 23DT Holdings, LLC, Indianapolis, IN, 3COOK® Medical, Bloomington, IN, 4 Indiana University School of Medicine, Indianapolis, IN 14
  • Meeting Program Chair: Steven Elias, MD Chair: Suresh Vedantham, MD Akhilesh Sista, MD Ellen Dillavou, MD Steven Elias, MD Peter J. Pappas, MD Suman Rathbun, MD Nick Morrison, MD Elna M. Masuda, MD Chair: Thom Rooke, MD Suresh Vedantham, MD Steven Dean, MD Chair: Thom Rooke, MD Steven Dean, MD Teresa Carman, MD Thom Rooke, MD Teresa Carman, MD Chair: Colleen Moore, MD Thom Rooke, MD Chair: Colleen Moore, MD Kathleen Ozsvath, MD Audra Duncan, MD Kathleen Ozsvath, MD Audra Duncan, MD Colleen Moore, MD & Manju Kalra, MD Chair: José Antonio Diaz, MD Colleen Moore, MD & Manju Kalra, MD Chairs: Ghassan Kassab, MD, Fedor Lurie, MD Seshadri Raju, MD Fedor Lurie, MD Alberto Smith, MD Michael Sacks, MD Daniel Myers, DVM Antonio Rosales, MD José Antonio Diaz, MD Zachary Berwick, MD Joseph D. Raffetto, MD
  • Poster Presentations Moderators: Joseph Raffetto, MD, Marc Passman, MD K. Gallagher, A. Obi, E. Hogikyan, D. Coleman, P. Henke; University of Michigan, Ann Arbor, MI A. T. Obi, R. Alvarez, B. N. Reames, M. J. Moote, M. A. Michigan, Ann Arbor, MI D. M. Coleman, J. Lee, J. Knepper, E. Andraska, T. B. Branco1, M. F. Montero-Baker1, L. R. Leon, Jr.2; 1 University of Arizona, Tucson, AZ, 2Pima Vascular, Tucson, AZ A. Y. Mousa, O. Moushmoush, M. Broce, S. AbuHalimah, M. Yacoub, G. Gill, S. M. Hass, P. Stone, A. F. AbuRahma; R. C. Byrd Health Sciences Center, W. Va.University, Charleston, WV Arbor, MI B. Branco1, M. F. Montero-Baker1, L. R. LEON, Jr.2; University of Arizona, Tucson, AZ, 2Pima Vascular, Tucson, AZ R. L. M. Kurstjens, M. A. F. de Wolf, S. A. Alsadah, I. M. Toonder, C. H. A. Wittens; Maastricht University Medical Centre, Maastricht, Netherlands J. El-Sheikha, S. Nandhra, T. Wallace, N. Samuel, D. Carradice, I. Chetter; Academic Vascular Unit Hull, Hull, United Kingdom R. de Graaf1, M. de Wolf1, C. Arnoldussen2, C. Wittens1, H. Jalaie3; 1Maastricht University Medical Centre, Maastricht, Netherlands, 2VieCuri Medical Centre, Venlo, Netherlands, 3Aachen University Hospital, Aachen, Germany, Aachen, Germany P. H. Carpentier1, R. Chamberod2, A. Cornu-Thénard2, J. Laurès2, J. Noilhetas2, E. Chauvin2; 1CHU Grenoble, Grenoble, France, 2Centre de Recherche Universitaire de La Léchère, La Léchère, France 1 E. Sanchez; The Cardiovascular and Vein Center, Bradenton, FL J. Shalhoub, H. M. Moore, K. Head, T. R. A. Lane, A. H. Davies; Imperial College London, London, United Kingdom N. C. Liew, L. Lee, S. K. Krishnan, G. B. Goh, N. F. Alimin, P. Hussin; University Putra Malaysia, UPM Serdang, Malaysia L. Lee, N. C. Liew; University Putra Malaysia, UPM Serdang, Malaysia K. Williams, A. H. Davies; Imperial College London, London, United Kingdom W. Tien1, H. Y. Chen2, Z. C. Berwick2, J. Krieger3, S. Chambers3, D. Dabiri1, G. Kassab2; 1Department of Aeronautics and Astronautics, University of Washington, Seattle, WA, 2Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, 3COOK Medical, Bloomington, IN
  • Poster Presentations K. H. Nagarsheth, K. Singh, J. Schor, B. George, P. Suen, J. Deitch; Staten Island University Hospital, Staten Island, NY E. V. Shaidakov1, V. L. Bulatov2, D. A. Rosukhovskiy1, O. I. Tsarev1, S. M. Khmelniker3; 1Institute of Experimental Medicine of the Russian Academy of Medical Sciences, St.Petersburg, Russian Federation, 2Institute of Bioregulation and Gerontology of the Russian Academy of Medical Sciences, St.Petersburg, Russian Federation, M. A. F. de Wolf1, C. W. K. P. Arnoldussen2, R. Kurstjens1, S. Penninx1, R. de Graaf1, C. H. A. Wittens1; 1 Maastricht University Medical Center, Maastricht, Netherlands, 2VieCuri Medical Center, Venlo, Netherlands 3 S. P. Rowland, B. Dharmarajah, H. M. Moore, A. H. Davies; Imperial College London, London, United Kingdom 17
  • Hotel & Travel Information The Roosevelt stands in the same place it has for more than 100 years, at the heart of all the history, cuisine, entertainment and culture that made New Orleans Here, in this little corner of the American South, where developed an exotic, spicy cuisine and were instrumental Royal Street. Immerse yourself in the constant buzz of one club to the next as you soak in a wealth of musical stylings at Preservation Hall or on Frenchmen Street. architecture comes in a carnival of tropical colors, irresistible. blocks of The Roosevelt, the rest of New Orleans is District, Magazine Street corridor, Garden District, and Roosevelt, all of New Orleans is yours to explore. On behalf of meeting participants, the American Venous Forum has reserved rooms at The Roosevelt for stately homes and historic mansions… a place like no other… a sensory overload with an authentic spirit… a way of life that began three centuries ago and remains today. Fly into Louis Armstrong New Orleans International drive from the airport with cab, car and shuttle service after the event. . After this date, (or once our reserved rooms have been sold) the group rate cannot be guaranteed. It is strongly The Roosevelt New Orleans 123 Baronne Street New Orleans, LA 70112 Driving directions to The Roosevelt can be found by February begins peak travel season in New Orleans, with average temperatures between 50 and 65 degrees Fahrenheit. Travelers without a US Passport may need to apply for a visitor visa. For additional information regarding obtaining a visa, visit the U.S. government website . Travelers entering the United States from all countries (including passport. If you need a letter of invitation for the Annual Meeting, please send an email to info@veinforum.org. 18
  • Registration Information AVF members should use the email address the AVF access, please mail or fax the Meeting Registration Form included in this brochure. American Venous Forum Tuesday . . . . . . . . . . ........ Thursday. . . . . . . . . . Friday . . . . . . . . . . . . cocktail reception, New Orleans cuisine and a live New Orleans jazz band. Tickets are available for attendees indicate the number of tickets you will need at the time of registration. In order to receive the discounted rate, registration must be received by the deadlines listed under Dates To Remember. All registrations received after will be subject to the onsite rates. Louisiana golf course, home of the PGA Tour’s Zurich two weeks prior to the PGA Tour and guarantees to be in excellent condition. The Golf Outing is scheduled for prior to the AVF Annual Meeting. Transportation to the way to relax and network on Tuesday afternoon before the Annual Meeting begins the following morning. Hall. transportation, greens fee, cart fee, practice balls, golf bag handling gratuity, personalized scorecards, staff gratuities, scoring summary, and contests. subscription. Spouse/Guest registration is by separate subscription and includes daily continental breakfast in the Hospitality order drawn on a U.S. bank made payable to the Hall. onsite. Specialty Sessions Only registration is available for attendees only interested in attending the Specialty Symposia on Friday afternoon. This registration type If written notice of cancellation is received by Friday, meeting. No refunds will be issued after this date.
  • Meeting Registration Form First Name Last Name Institution Address You must be registered for the Annual Meeting to register for this course. (All registrations must be post-marked and paid in full on or before deadlines noted.) ** This fee includes attendance to two Specialty Symposium Sessions on Friday afternoon. Select this option if you are ONLY planning to attend the Specialty Symposium sessions. (Specialty Symposia are included (A) Deep Venous Disease (B) Vascular Medicine & Thrombosis (F)Vascular Medicine & Thrombosis (D) Animal Models in Venous Research Please provide the name of your spouse/guest below. No, I will not attend. All Mardi Gras Soirée attendees MUST purchase a ticket to attend. Tickets must be purchased during advance registration and cannot be guaranteed on-site. 20
  • Meeting Registration Form Yes, I will attend No, I will not attend. Please provide the names of your preferred tournament pairings: Handicap: Mastercard VISA Discover Billing Address American Venous Forum 21
  • American Venous Forum